Association of PD-L1 expression with treatment outcomes in patients with
<i>BRAF</i>
mutation-positive melanoma treated with vemurafenib or cobimetinib combined with vemurafenib

Association of PD-L1 expression with treatment outcomes in patients with BRAF mutation-positive melanoma treated with vemurafenib or cobimetinib combined with vemurafenib

Wongchenko, Matthew J.; Ribas, Antoni; Dréno, Brigitte; Ascierto, Paolo A.; McArthur, Grant A.; Gallo, Jorge D.; Rooney, Isabelle A.; Hsu, Jessie; Koeppen, Hartmut; Yan, Yibing; Larkin, James

期刊名称Pigment Cell & Melanoma Research
作者Wongchenko, Matthew J.; Ribas, Antoni; Dréno, Brigitte; Ascierto, Paolo A.; McArthur, Grant A.; Gallo, Jorge D.; Rooney, Isabelle A.; Hsu, Jessie; Koeppen, Hartmut; Yan, Yibing; Larkin, James
印刷ISSN1755-1471
文件大小740.59KB
发表时间2017-11-20
DOI10.1111/pcmr.12670

发现好书期刊，享受阅读乐趣

Association of PD-L1 expression with treatment outcomes in patients with BRAF mutation-positive melanoma treated with vemurafenib or cobimetinib combined with vemurafenib